Joseph Sollee - MDxHealth President
MXDHFDelisted Stock | USD 3.44 0.23 7.17% |
President
Mr. Joseph Sollee was Executive Vice President, Chief Compliance Officer, General Counsel of MDxHealth SA since 2017. He was Executive Vice President Corporationrationrate Development and Legal Affairs at the Company from 2010. He has provided legal counsel to MDxHealth since its inception in 2003, and in April 2008 joined the management team. rior to joining the Company, Mr. Sollee served as Special Counsel with the law firm of Kennedy Covington, where he led the Life Sciences Practice Group. Mr. Sollee has more than 10 years of experience in the biotech industry, and has held senior legal and management positions at Triangle Pharmaceuticals and TherapyEdge. In addition, he has practiced as a corporate attorney in the Washington D.C. legal firm Swidler Berlin and as an investment banker at Smith Barney in New York since 2017.
Age | 58 |
Tenure | 7 years |
Phone | 32 4 257 70 21 |
Web | https://mdxhealth.com |
MDxHealth Management Efficiency
The company has return on total asset (ROA) of (0.3869) % which means that it has lost $0.3869 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.3191) %, meaning that it generated substantial loss on money invested by shareholders. MDxHealth's management efficiency ratios could be used to measure how well MDxHealth manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 7.65 M in total debt with debt to equity ratio (D/E) of 0.48, which is about average as compared to similar companies. MDxHealth SA has a current ratio of 2.33, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist MDxHealth until it has trouble settling it off, either with new capital or with free cash flow. So, MDxHealth's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MDxHealth SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MDxHealth to invest in growth at high rates of return. When we think about MDxHealth's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | PRESIDENT Age | ||
Bruno Lavandier | Ecolab Inc | 50 | |
Jill Wyant | Ecolab Inc | 49 | |
Steven Eaton | NL Industries | 61 | |
James Leyden | Teleflex Incorporated | 52 | |
P Farabaugh | Park Electrochemical | 59 | |
Oliver Guiot | Hawkins | 38 | |
Amy Samford | NL Industries | 50 | |
Roger Graham | Teleflex Incorporated | N/A | |
Alex Blanco | Ecolab Inc | 57 | |
Lisa Kudlacz | Teleflex Incorporated | N/A | |
Steven Matthews | Hawkins | 46 | |
Andrew Louis | NL Industries | 55 | |
Timothy Mulhere | Ecolab Inc | 61 | |
Mark Esquivel | Park Electrochemical | 51 | |
Kelly Luttmer | NL Industries | 55 | |
Stephen Taylor | Ecolab Inc | 54 | |
Laurie Marsh | Ecolab Inc | 60 | |
Paul Farabaugh | Park Electrochemical | 56 | |
Darrell Brown | Ecolab Inc | 60 | |
Walter Precourt | The Mosaic | 55 | |
Jake Newman | Teleflex Incorporated | N/A |
Management Performance
Return On Equity | -1.32 | |||
Return On Asset | -0.39 |
MDxHealth SA Leadership Team
Elected by the shareholders, the MDxHealth's board of directors comprises two types of representatives: MDxHealth inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MDxHealth. The board's role is to monitor MDxHealth's management team and ensure that shareholders' interests are well served. MDxHealth's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MDxHealth's outside directors are responsible for providing unbiased perspectives on the board's policies.
Wim Criekinge, Chief Scientific Officer | ||
Jan Pensaert, Non-Executive Director | ||
Jan Groen, CEO and President and Executive Director | ||
Mark Shaffar, Non-Executive Independent Chairman of the Board | ||
Mark Myslinski, Non-Executive Independent Director | ||
Christopher Thibodeau, Chief Commercial Officer and Executive VP | ||
Paul Marr, Ex America | ||
Rudi Marien, Non-Executive Director, representing Gengest BVBA | ||
Edward Erickson, Chairman, Non-Executive Independent Director | ||
Michael McGarrity, CEO, Director | ||
Joseph Sollee, Executive Vice President - Corporate Development and Legal Affairs | ||
Rudi Pauwels, Independent Director | ||
John Bellano, Chief Officer | ||
Francis Ota, Executive VP of Fin. | ||
Joseph Bigley, Vice President - Clinical Affairs | ||
Ruth Devenyns, Non-Executive Independent Director | ||
MingChou Lee, Vice President - Product Development | ||
Miriam Reyes, Vice President - Laboratory Operations | ||
Walter Narajowski, Non-Executive Independent Director | ||
JeanMarc Roelandt, Executive Vice President & CFO | ||
Ron Kalfus, Chief Officer |
MDxHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is MDxHealth a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.32 | |||
Return On Asset | -0.39 | |||
Profit Margin | (1.32) % | |||
Operating Margin | (1.12) % | |||
Current Valuation | 85.65 M | |||
Shares Outstanding | 262.88 M | |||
Shares Owned By Insiders | 15.72 % | |||
Shares Owned By Institutions | 49.20 % | |||
Price To Earning | (18.67) X | |||
Price To Book | 3.56 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the MDxHealth SA information on this page should be used as a complementary analysis to other MDxHealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in MDxHealth Pink Sheet
If you are still planning to invest in MDxHealth SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MDxHealth's history and understand the potential risks before investing.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |